Ola Farouk Leheta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ola Farouk Leheta has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Mohamed Mossad
Department of Internal medicine and Endocrinology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
1 shared publication - Ann Hegazy
Department of clinical pathology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt
1 shared publication - Marina Farid
Pediatrics and Neonatology Department, Faculty of Medicine, Suez Canal University, Egypt
1 shared publication Mohamed Osama Abdalla
Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Egypt
1 shared publicationMohammad Tawfik
Pediatrics and Neonatology Department, Faculty of Medicine, Suez Canal University, Egypt
1 shared publication- Rana Belal Mohammad
Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
1 shared publication
Latest Publications
- Open Access
- 5 July 2025
- Published by Egyptian Knowledge Bank in Suez Canal University Medical Journal
- Vol. 28 (7) , 11-18
Hematological Parameters Versus C-reactive Protein Role in The Diagnosis of Late Onset Neonatal Sepsis in Full Term Neonates at Suez Canal University Hospital
Background: Late-onset sepsis is a major cause of morbidity and death in neonates. Diagnosis may be complex. Hematological markers and C-reactive protein (CRP) are regularly measured as part of sepsis screening. However, the gold standard for diagnosing sepsis is the isolation of microorganisms in a blood culture. Aim: This study aimed to compare the role of hematological parameters versus CRP as diagnostic markers for late-onset neonatal sepsis (LONS) in full-term neonates. Patients & Methods: This case-control study included 50 neonates with LONS admitted to the Neonatal Intensive Care Unit (NICU) of Suez Canal University Hospital & 50 healthy controls both groups were rigorously investigated, including anthropometric data, clinical symptoms, key biomarkers, including CBC parameters & serum CRP. Results: Among the sepsis group, 43 patients (86%) had positive blood culture results as klebsiella (32%) & mixed organisms had the highest prevalence among positive results, staph (16%) & E.coli (8%). The Sepsis group had a significantly lower mean of Hemoglobin, platelets, & Platelet lymphocytic ratio than the control group with p-value <0.05.The Sepsis group had a significantly higher mean of C-reactive protein, C-reactive protein /Mean platelet volume and C-reactive protein /Albumin than the control group as p- value <0.001. CRP had the best sensitivity (100%), whereas CRP/MPV was more specific (100%). Conclusion: CRP has very good sensitivity for the diagnosis of LONS, while in combination with MPV gave more specificity for the diagnosis of LONS
- 5 July 2025
- Published by Egyptian Knowledge Bank in Suez Canal University Medical Journal
- Vol. 28 (7) , 11-18
Open AccessHematological Parameters Versus C-reactive Protein Role in The Diagnosis of Late Onset Neonatal Sepsis in Full Term Neonates at Suez Canal University Hospital
Background: Late-onset sepsis is a major cause of morbidity and death in neonates. Diagnosis may be complex. Hematological markers and C-reactive protein (CRP) are regularly measured as part of sepsis screening. However, the gold standard for diagnosing sepsis is the isolation of microorganisms in a blood culture. Aim: This study aimed to compare the role of hematological parameters versus CRP as diagnostic markers for late-onset neonatal sepsis (LONS) in full-term neonates. Patients & Methods: This case-control study included 50 neonates with LONS admitted to the Neonatal Intensive Care Unit (NICU) of Suez Canal University Hospital & 50 healthy controls both groups were rigorously investigated, including anthropometric data, clinical symptoms, key biomarkers, including CBC parameters & serum CRP. Results: Among the sepsis group, 43 patients (86%) had positive blood culture results as klebsiella (32%) & mixed organisms had the highest prevalence among positive results, staph (16%) & E.coli (8%). The Sepsis group had a significantly lower mean of Hemoglobin, platelets, & Platelet lymphocytic ratio than the control group with p-value <0.05.The Sepsis group had a significantly higher mean of C-reactive protein, C-reactive protein /Mean platelet volume and C-reactive protein /Albumin than the control group as p- value <0.001. CRP had the best sensitivity (100%), whereas CRP/MPV was more specific (100%). Conclusion: CRP has very good sensitivity for the diagnosis of LONS, while in combination with MPV gave more specificity for the diagnosis of LONS
- 28 November 2024
- Published by Egyptian Knowledge Bank in Suez Canal University Medical Journal
- Vol. 27 (11)
Serum and Urinary Fatty Acid-Binding Protein 1 Levels as Markers for Diabetic Nephropathy in Type II Diabetes Mellitus
Background:Diabetic nephropathy is considered a main microvascular complication of diabetes mellitus (DM) that results in chronic renal failure. Fatty acid-binding protein 1 (FABP1) is expressed in renal proximal tubule cells and released into urine as a result of hypoxia triggered by decreased peritubular capillary blood flow, consequently urinary FABP1 is seen as a hopeful indicator for monitoring tubulointerstitial injury. There is increasing evidence that FABP1 plays a role in the development and progression of chronic kidney disease. Aim: This study aimed to assess the correlation of circulating plasma FABP1 level as well as its urinary level to nephropathy in patients with type 2 diabetes mellitus.Methods: Ninety patients were recruited, divided into 3 groups. They were investigated for glycemic and renal biomarkers, then FABP1 concentration was measured in their serum and urine samples. Bioinformatic analysis was done to explore the relation between FABP1 and DN. Results: The presence of DN was associated with increase in both serum and urinary FABP1. A serum FABP1 concentration of >243 ng/L was associated with DN, with a sensitivity of 93% and specificity of 90%, while urinary FABP1 concentration of >155.67 ng/L was associated with DN, with a sensitivity of 90% and specificity of 73%. Bioinformatic analysis revealed interactions between FABP1 and other kidney markers. Conclusion: This study proved that serum and urinary levels of FABP1 were significantly higher in the DN group than the normo-albuminuric groups reflecting the progression of the disease, thus they can be used as diagnostic biomarkers with significant sensitivity and specificity.
- 28 November 2024
- Published by Egyptian Knowledge Bank in Suez Canal University Medical Journal
- Vol. 27 (11)
Serum and Urinary Fatty Acid-Binding Protein 1 Levels as Markers for Diabetic Nephropathy in Type II Diabetes Mellitus
Background:Diabetic nephropathy is considered a main microvascular complication of diabetes mellitus (DM) that results in chronic renal failure. Fatty acid-binding protein 1 (FABP1) is expressed in renal proximal tubule cells and released into urine as a result of hypoxia triggered by decreased peritubular capillary blood flow, consequently urinary FABP1 is seen as a hopeful indicator for monitoring tubulointerstitial injury. There is increasing evidence that FABP1 plays a role in the development and progression of chronic kidney disease. Aim: This study aimed to assess the correlation of circulating plasma FABP1 level as well as its urinary level to nephropathy in patients with type 2 diabetes mellitus.Methods: Ninety patients were recruited, divided into 3 groups. They were investigated for glycemic and renal biomarkers, then FABP1 concentration was measured in their serum and urine samples. Bioinformatic analysis was done to explore the relation between FABP1 and DN. Results: The presence of DN was associated with increase in both serum and urinary FABP1. A serum FABP1 concentration of >243 ng/L was associated with DN, with a sensitivity of 93% and specificity of 90%, while urinary FABP1 concentration of >155.67 ng/L was associated with DN, with a sensitivity of 90% and specificity of 73%. Bioinformatic analysis revealed interactions between FABP1 and other kidney markers. Conclusion: This study proved that serum and urinary levels of FABP1 were significantly higher in the DN group than the normo-albuminuric groups reflecting the progression of the disease, thus they can be used as diagnostic biomarkers with significant sensitivity and specificity.